Skip to main content

Table 1 Patient characteristics

From: The association of diabetes mellitus treated with oral antidiabetic drugs and insulin with mortality after transcatheter valve implantation: a 3-year follow-up of the TAVIK registry

 

Without diabetes (n = 1337)

Diabetes on OAD (n = 387)

Diabetes on insulin (n = 276)

p-value

Age (years)

82.30 ± 5.51

81.35 ± 5.12

79.75 ± 5.49

< 0.001

Male gender

590 (44.1)

182 (47.0)

140(50.7)

0.110

LVEF (%)

57.57 ± 13.07

56.37 ± 13.77

53.85 ± 14.63

0.001

PAD

187 (14.0)

60 (15.5)

71 (25.7)

0.067

CAD

767 (57.4)

251 (64.9)

199 (72.1)

< 0.001

Previous CABG

173 (12.9)

62 (16.0)

68 (24.6)

< 0.001

Previous MI

137 (10.2)

49 (12.7)

39 (14.1)

0.110

COPD (moderate/severe)

150 (11.2)

52 (13.4)

33 (12.0)

0.488

Mitral valve disease (> II°)

174 (13.0)

48 (12.4)

38 (13.8)

0.875

Porcelain aorta

88 (6.6)

26 (6.7)

14 (5.1)

0.621

Log. EuroSCORE I

20.46 ± 14.52

20.60 ± 15.12

24.69 ± 18.17

< 0.001

Carotid stenosis

231 (17.3)

74 (19.1)

64 (23.2)

0.065

Previous valve surgery

46 (3.4)

14 (3.6)

5 (1.8)

0.344

Major neurological deficits

128 (9.6)

32 (8.3)

40 (14.5)

0.021

Critical perioperative situation

19 (1.4)

3 (0.8)

6 (2.2)

0.310

Pulmonary hypertension (moderate/severe)

277 (20.7)

68 (17.6)

69 (25.0)

1.0

Renal failure incl. dialysis

53 (4.0)

25 (6.5)

30 (10.9)

< 0.001

Emergency case

15 (1.1)

7 (1.8)

6 (2.2)

0.157

Overall frailty

412 (30.8)

141 (36.4)

114 (41.3)

0.001

NYHA IV

88 (6.6)

27 (7.0)

32 (11.6)

0.014

  1. CABG coronary artery bypass graft, CAD coronary artery disease, LVEF left ventricular ejection fraction, MI myocardial infarction, PAD peripheral artery disease, COPD chronic obstructive pulmonary disease